Doc. Ref. EMEA/CHMP/410869/2006

← Back to document page

Also, donation, procurement and testing of cells from human origin must comply with overarching Directive 2004/23/EC. 4. and technical directives drawn from it, Directives 2006/17/EC. 5 . and 2006/86/EC. 6. 4. MAIN GUIDELINE TEXT . 4.1. Risk analysis . The risk posed by the administration of a cell-based medicinal product is highly dependent on the

  Testing